SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-015209
Filing Date
2024-05-08
Accepted
2024-05-08 07:49:18
Documents
87
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q clnn20240331c_10q.htm   iXBRL 10-Q 1604132
2 EXHIBIT 31.1 ex_622058.htm EX-31.1 12743
3 EXHIBIT 31.2 ex_622059.htm EX-31.2 12508
4 EXHIBIT 32.1 ex_622060.htm EX-32.1 6091
5 EXHIBIT 32.2 ex_622061.htm EX-32.2 6024
11 newpipeline.jpg GRAPHIC 112808
  Complete submission text file 0001437749-24-015209.txt   9504032

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA clnn-20240331.xsd EX-101.SCH 90939
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clnn-20240331_cal.xml EX-101.CAL 61048
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clnn-20240331_def.xml EX-101.DEF 550504
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE clnn-20240331_lab.xml EX-101.LAB 531650
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clnn-20240331_pre.xml EX-101.PRE 592558
91 EXTRACTED XBRL INSTANCE DOCUMENT clnn20240331c_10q_htm.xml XML 1650739
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

IRS No.: 852828339 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39834 | Film No.: 24924278
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)